MOCHIDA PHARMACEUTICAL CO., LTD.
232Patents
112Active
232Granted
51Portfolio score
Filing activity: Jul 9, 1976 → Dec 21, 2023 · 24 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5730124A | Medical measurement apparatus | Physics | 448 | Expired |
| US5609749A | Electrochemical assay method with novel p-phenylenediamine compound | Emerging Cross-Sectional Technologies | 195 | Expired |
| US7498359B2 | Composition and method for preventing recurrence of stroke | Human Necessities | 149 | Active |
| US5723345A | Method and device for specific binding assay | Emerging Cross-Sectional Technologies | 138 | Expired |
| US8618168B2 | Self-emulsifying composition of OMEGA3 fatty acid | Human Necessities | 107 | Active |
| US5266491A | DNA fragment and expression plasmid containing the DNA fragment | Chemistry; Metallurgy | 106 | Expired |
| US5219762A | Method and device for measuring a target substance in a liquid sample | Emerging Cross-Sectional Technologies | 104 | Expired |
| US9452150B2 | Jelly composition | Human Necessities | 96 | Active |
| US9060981B2 | Marker associated with non-alcoholic steatohepatitis | Physics | 95 | Active |
| US9006285B2 | Therapeutic agent for hepatitis C | Human Necessities | 91 | Active |
| US4479720A | Apparatus for rotating reaction vessels in inclined posture | Emerging Cross-Sectional Technologies | 89 | Expired |
| US5147607A | Reaction vessel with a rocking base | Emerging Cross-Sectional Technologies | 86 | Expired |
| US5225348A | DNA fragment and expression plasmid containing the DNA fragment | Chemistry; Metallurgy | 76 | Expired |
| US5158748A | Automated dispensing and diluting system | Physics | 74 | Expired |
| US5149540A | Thrombin composition for oral administration | Human Necessities | 72 | Expired |
| US6040331A | Nerve cell protective agents | Chemistry; Metallurgy | 63 | Expired |
| US6387938B1 | Benzimidazole derivatives | Chemistry; Metallurgy | 62 | Expired |
| US5610016A | Method for measuring adenyl group-containing substances using heteropoly-acid | Emerging Cross-Sectional Technologies | 52 | Expired |
| US8853256B2 | Composition for preventing the occurrence of cardiovascular event in multiple risk patient | Human Necessities | 51 | Active |
| US8802718B2 | Composition for preventing the occurrence of cardiovascular event in multiple risk patient | Human Necessities | 47 | Active |
| US9700537B2 | Composition for preventing the occurrence of cardiovascular event in multiple risk patient | Human Necessities | 45 | Active |
| US6218134A | Process for specific binding assay for measuring the amount of analyte in a liquid test sample | Emerging Cross-Sectional Technologies | 45 | Expired |
| US5866321A | Analytical method and device for precise analysis with a simple sensor | Physics | 42 | Expired |
| US7494987B2 | Agent for treating respiratory diseases containing 4-hydroxypiperidine derivative as active ingredient | Chemistry; Metallurgy | 41 | Expired |
| US5409895A | Protease inhibitory polypeptides derived from urinary trypsin inhibitor and compositions thereof | Chemistry; Metallurgy | 40 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.